Rel- (E) -BMY 21950 (sodium)

CAT: 0804-HY-105281Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-105281Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Rel- (E) -BMY 21950 sodium is the relative configuration of BMY 21950. BMY 21950 is an HMG-CoA reductase inhibitor. BMY 21950 inhibits hepatic cholesterol synthesis[1].

CAS Number

130200-44-1

UNSPSC

12352005

Target

Drug Derivative

Related Pathways

Others

Field of Research

Metabolic Disease

Smiles

FC(C=C1)=CC=C1/C(C2=CC=C(F)C=C2)=C(C3=NN=NN3C)\C=C\[C@@H](O)C[C@@H](O)CC(O[Na])=O

Molecular Formula

C23H21F2N4NaO4

Molecular Weight

478.42

References & Citations

[1]Parker RA, et al. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors. J Lipid Res. 1990 Jul;31 (7) :1271-82.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Related Products

Catalog	Name
HY-14879E	Rel-Avibactam (sodium)
HY-N0683A-01	Rel-α-Vitamin E
HY-108565-01	BMY 45778
HY-100554-01	BMY 7378
HY-106809-01	BMY-21502
HY-19010	BMY-25368
HY-105361	BMY 25282
HY-119213-01	BMY-27709
HY-105482	BMY 20844
HY-100191	BMY-25271

Alternative Products

Catalog	Name
GTR19273627-01	Rel- (E) -BMY 21950 sodium
T30550-01	BMY-21950
GTR19274538-01	Rel-Avibactam sodium
TRC-C587325-10MG	(5Z)-rel-Cloprostenol Sodium
437469-01	(5Z) -rel-Cloprostenol Sodium
TDA95758-01	Rel- (3R,5R) -fluvastatin sodium
TRC-F601215-5MG	rel-(3R,5R)-Fluvastatin Sodium
OR1065411-01	Rel-Potassium sodium (2R,3R) -2,3-dihydroxysuccinate tetrahydrate
OR1066347	Sodium rel- (2R,3R) -3-carboxy-2,3-dihydroxypropanoate
TRC-D453145-50MG	(2R,3R)-rel-2,3-Dihydroxy-2-methylbutanoic Acid Sodium Salt

Rel- (E) -BMY 21950 (sodium)

Related Products

Alternative Products

Popular Products